Knoll Capital Management, LLC - 14 Nov 2024 Form 3 Insider Report for Entera Bio Ltd. (ENTX)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
20 Nov 2024, 13:53:33 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Fred Knoll

Key filing fact

Knoll Capital Management, LLC filed Form 3 for Entera Bio Ltd. (ENTX) on 20 Nov 2024.

Key facts

  • This page summarizes Knoll Capital Management, LLC's Form 3 filing for Entera Bio Ltd. (ENTX).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 20 Nov 2024, 13:53.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENTX holding

Ordinary Shares, par value NIS 0.0000769 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,534,275
Date
14 Nov 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENTX holding Derivative

Pre-funded warrant

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
14 Nov 2024
Ownership
Direct
Underlying class
Ordinary Shares, par value NIS 0.0000769 per share
Underlying amount
347,604
Exercise price
$0.000000
ENTX holding Derivative

Warrants (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
14 Nov 2024
Ownership
Direct
Underlying class
Ordinary Shares, par value NIS 0.0000769 per share
Underlying amount
1,197,604
Exercise price
$1.00
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

* Gakasa beneficially owns 5,534,275 Shares of the Issuer's Common Stock and 347,604 pre-funded warrants. Each of KCM and Knoll beneficially own 5,534,275 Shares of the Issuer's Common Stock and 347,604 pre-funded warrants. KCM has trading authority for Gakasa, and Knoll is the President of KCM. KCM is a limited liability company formed and existing under the laws of the State of Florida. Knoll is a citizen of the United States. Gakasa is a limited liability company organized under the laws of the State of Florida.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .